Sort
78,016 grants matching “breast cancer”
Cognition In Older Breast Cancer Survivors: Treatment Exposure, APOE, & Smoking
$678,683Tim Alan Ahles · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
Impact of BRCA Testing on Newly Diagnosed U.S. Breast Cancer Patients
$678,656Rebecca Sutphen · University Of South Florida · R01 · FY2017 · CA
EEG Biomarkers Derived from Dynamical Network Models Enable Rapid Paths to Accurate Diagnosis and Effective Treatment of Epilepsy
$678,609Sridevi V. Sarma · Johns Hopkins University · R35 · FY2024 · NS
Proteolysis targeting chimera against nuclear receptor NR4A1 for melanoma therapy
$678,605Weizhou Zhang · University Of Florida · R01 · FY2024 · CA
Improving medication adherence using a CONnected CUstomized Treatment Platform (CONCURxP)
$678,579Gelareh Sadigh · University Of California-Irvine · R01 · FY2022 · CA
Role of necrosis in the evolution of highly metastatic and chemo-resistant breast cancers
$678,482Kevin Jon Cheung · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
TARGETING PCD FOR CANCER THERAPY
$678,476University Of Michigan At Ann Arbor · P01 · FY2000 · CA
Clinical Pharmacogenetics
$678,469William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Therapeutic Targeting of Casein Kinase-1-delta in Primary and Metastatic Breast Cancer
$678,459Derek Ronald Duckett · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2018 · CA
Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer
$678,424Moran Amit · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · DE
Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer
$678,424Moran Amit · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · DE
High Throughput Screening to Discover Chemical Inhibitors of Quiescin Sulfhydryl Oxidase 1
$678,423Douglas Faigel · Mayo Clinic Arizona · R01 · FY2017 · CA
Strategies for Reaching and Impacting Our Communities Sustainably (NWP-ROCS Program)
$678,392Rachel C Shelton · Columbia University Health Sciences · R01 · FY2025 · CA
Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics
$678,352Phil Crews · University Of California Santa Cruz · R01 · FY2013 · CA
Multimarker Risk Prediction in Cancer Therapy Cardiotoxicity
$678,320Bonnie Ky · University Of Pennsylvania · R01 · FY2018 · HL
CAM Approaches to Management of Sleep and Disease Progression in Cancer
$678,314David Spiegel · Stanford University · P30 · FY2010 · AT
Genetic Predisposition to Chronic Lymphocytic Leukemia (CLL)
$678,292Jennifer R Brown · Dana-Farber Cancer Inst · R01 · FY2021 · CA
A biophysical stromal basis for radiation sensitivity in ductal carcinoma in situ
$678,168Catherine C Park · University Of California, San Francisco · R01 · FY2014 · CA
Night Shift Work and Hormone Levels in Men
$678,144Scott Davis · Fred Hutchinson Cancer Research Center · R01 · FY2007 · CA
EVALUATION OF STAT3 ANTAGONISTS IN THE PREVENTION OF MAMMARY CANCER
$678,114Clinton Grubbs · University Of Alabama At Birmingham · N01 · FY2018 · CA
Simulating Protein Structures, Complexes, And Dynamics
$678,089Peter J Steinbach · Center For Information Technology · ZIA · FY2016 · CT
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
$678,087Griffin Rodgers · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
FFPE Validation of a Survival Gene Signature in HPV-Negative Oral Cavity Cancer
$678,016Chu Chen · Fred Hutchinson Cancer Research Center · R01 · FY2016 · CA
Tumor gene expression in vitro and in vivo
$677,938Douglas R. Lowy · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Angiogenesis imaging
$677,802Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA